Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.


Abstract

The overall survival of patients with BM-MM primarily depends on the number of metastases and pretreatment level of LDH. In the case of a single brain metastasis, stereotactic radiotherapy or neurosurgical metastasectomy is by far the most important factor for improving survival.


Full Text


Subjects


Similar articles

Authors


Publication date

2011-04-07


Journal

Cancer
Cancer (0008-543X)

Journal topics


Language

Eng.


Copyright

Cancer

Division of Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.


Release reference

Cancer. 2011 Apr;117(8):1697-703



Related books


Español | English

© Galenicom 1999-2013